Can-Fite Biopharma CANF
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q2 | 21.00 | 4 | 8 | |||
| 2024Q4 | 32.50 | 5 | 9 | |||
| 2024Q2 | 51.60 | 2 | 6 | |||
| 2023Q4 | 44.00 | 6 | -28.79 | -2 | -17.25 | 10 |
| 2023Q3 | 53.00 | 5 | -29.10 | -2 | -17.44 | 9 |
| 2023Q2 | 61.40 | 7 | -21.73 | -2 | -13.62 | 11 |
| 2023Q1 | 45.80 | 8 | -39.34 | -3 | -22.40 | 13 |
| 2022Q4 | 122.60 | 4 | -50.74 | -3 | -27.46 | 9 |
| 2022Q3 | 153.98 | 7 | -29.20 | -3 | -18.42 | 13 |
| 2022Q2 | 184.00 | 10 | -19.99 | -2 | -13.44 | 15 |
| 2022Q1 | 248.00 | 12 | -18.44 | -2 | -12.78 | 18 |
| 2021Q4 | 258.00 | 14 | -34.73 | -4 | -23.60 | 20 |
| 2021Q3 | 332.00 | 9 | -51.17 | -3 | -27.96 | 15 |
| 2021Q2 | 456.00 | 4 | -18.83 | -3 | -14.82 | 10 |
| 2021Q1 | 494.00 | 30 | -39 | -208.70 | 34 | |
| 2020Q4 | 356.00 | -4 | 2 | 46.70 | 3 | |
| 2020Q3 | 354.00 | -6 | -3 | -29.89 | 7 | |
| 2020Q2 | 396.00 | -3 | -4 | -29.77 | 14 | |
| 2020Q1 | 262.00 | -4 | -4 | 11 |